Dino Nisato

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

C. Serradeil‐Le Gal, Jean Wagnon, Corinne Garcia et al. · Journal of Clinical Investigation · 1993 · 272 citations · Full text

Avp V2, Immunology, Pharmacotherapy +18

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

C. Serradeil‐Le Gal, C Lacour, G Valette et al. · Journal of Clinical Investigation · 1996 · 247 citations · Full text

Molecular Pharmacology, Selective Affinity, Arginine Vasopressin +14

Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist

Claudine Serradeil‐Le Gal, Jean Wagnon, Jacques Simiand et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 207 citations · Full text

Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acid

Patrick Jouin, Bertrand Castro, Dino Nisato · Journal of the Chemical Society Perkin Transactions 1 · 1987 · 188 citations

Enantioselective Synthesis, Engineering, Stereospecific Synthesis +13

A novel class of calcium-entry blockers: the 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines

J. Gubin, J. Lucchetti, Jean Mahaux et al. · Journal of Medicinal Chemistry · 1992 · 134 citations